
German, Swiss pharma firms tour Ghana to scout partnerships with local manufacturers
Three German companies and one Swiss firm spent three days meeting Ghanaian drug makers and regulators under the EUR33 million PharmaVax Ghana program, aimed at pairing European technology with local production and expansion plans.





